Seminar Briefing

From Office of Health Economics
Contact information at EDIRC.
Bibliographic data for series maintained by Publications Manager ( this e-mail address is bad, please contact ).

Access Statistics for this working paper series.
Is something missing from the series or not right? See the RePEc data check for the archive and series.

002303: How do we Measure the “Value” in Value-Based care?

Ian McKenna

002289: Incentives for R&D: Payment Options and Pricing Challenges

Pedro Barros

002266: Personalised Medicine: is it an Oil-Rush or Oil-Spill?

Alistair McGuire

002259: Closing the ‘Know-Do’ Gap for Health Systems Reform at the Policy Level

David Hunter and Rafael Bengoa

002246: What NHS Trusts Can Do to Reduce Waiting Times for Cancer Treatment

Julia Gonzalez-Esuerra;Sarah Karlsberg;Steven Paling

002245: Evaluating the Cost-effectiveness of Health System Strengthening: A Platforms Perspective

Peter Smith

002112: Early Experience with Health Technology Assessment of Gene Therapies in the United States: Pricing and Paying for Cures

Dr Steven Pearson

002000: The UK Biotech Sector and Brexit: Past Performance and Future Prospects

Sir Geoffrey Owen;Michael Hopkins

001942: NHS Agency Staffing and the Impact of Recent Interventions

Chris Mullin

001880: Interventions that Encourage High-value Nursing Home Care: Lessons for the UK

David Grabowski

001804: Delivering an Outcomes-based NHS: Creating the Right Conditions

Nick Hicks

001724: Waiting Time Policies in the Health Sector

Luigi Siciliani

001653: Multi-indication Pricing: Pros, Cons and Applicability to the UK

Adrian Towse

001616: Improving the Fiscal and Political Sustainability of Health Systems through Integrated Population Needs-Based Planning

Stephen Birch

001589: A Framework for Payer Assessment of the Value of New Technologies: A US Approach

Office of Health Economics

001556: Biosimilar Competition: Lessons from Europe and Prospects for the US

Henry G. Grabowski

000482: Mental Health Economics and Policy in a Global Context

Office of Health Economics

000478: Making the best of the Private Finance Initiative in the NHS

Office of Health Economics

000454: The New NHS: What Can We Learn From Managed Care in New Zealand and the US?

Nick Goodwin

000451: Public Involvement in Priority Setting

Lisa Gold

000449: Leadership, Change and Primary Care Groups

Louise Locock

000219: Innovation in Medicines: Can We Value Progress?

Office of Health Economics

000197: Science Policy Research: Having an Impact on Policy?

Ben Martin

000193: Priority Review Vouchers to Encourage Innovation for Neglected Diseases

Henry G. Grabowski

000173: Willingness to Pay and Publicly Funded Health Care: Contradiction in Terms?

Cam Donaldson

000146: Is There a Productivity Crisis in Pharmaceutical R&D?

Massimo Riccaboni

000141: Value Based Pricing in Sweden: Lessons for Design?

Ulf Persson

000077: Real Option Value and Path Dependence in Oncology Innovation

Joseph P Cook

000074: Can the US Afford to Ignore Cost-effectiveness Evidence?

James Chambers